Cerebellar transcranial magnetic stimulation to treat drug‐resistant epilepsy: A randomized, controlled, crossover clinical trial

• Published in: Epilepsia (Copenhagen) Vol. 66; no. 1; pp. 240 - 252
• Main Authors: Wang, Yuan‐Yuan, Ma, Lei, Shi, Xiao‐Jing, Liu, Yu, Wu, Dian‐Wei, Hao, Jian‐Min, Leng, Xiu‐Xiu, Jin, Lang, Yuan, Fang, Sun, Zhong‐Qing, Zhao, Jing‐Jing, Wang, Ling, Shang, Lei, Wang, Duo‐Lao, Song, Chang‐Geng, Jiang, Wen
• Format: Journal Article
• Language: English
• Published: United States Wiley Subscription Services, Inc 01.01.2025
• Subjects: Achievement tests; Adolescent; Adult; Anticonvulsants; Cerebellum; Cerebellum - physiopathology; Clinical trials; continuous theta burst stimulation; Convulsions & seizures; Cross-Over Studies; Dentate nucleus; Drug Resistant Epilepsy - physiopathology; Drug Resistant Epilepsy - therapy; drug‐resistant epilepsy; Epilepsy; Female; Humans; Magnetic fields; Male; Middle Aged; Patients; randomized crossover trial; Seizures; Tinnitus; Transcranial magnetic stimulation; Transcranial Magnetic Stimulation - methods; Treatment Outcome; Young Adult; drug‐resistant epilepsy; continuous theta burst stimulation; randomized crossover trial; transcranial magnetic stimulation; cerebellum

Objective Epilepsy is one of the most prevalent brain diseases. Approximately one third of patients consistently experience drug‐resistant epilepsy (DRE), a condition where seizures persist despite the use of antiseizure medications. Exploration of new therapies for DRE is urgently needed. In this s...